Vaccines and Preventable Diseases:
Mumps - Reporting
On this page:
Information on this page was adapted from the Manual for the Surveillance of Vaccine-Preventable Diseases (4th Edition, 2008), Chapter 9: Mumps
Reporting
Each state and territory has regulations or laws governing the reporting of diseases and conditions of public health importance. These regulations and laws list the diseases that are to be reported and describe those persons or groups responsible for reporting, such as health-care providers, hospitals, schools, laboratories, daycare and childcare facilities, and other institutions.
Contact the state health department for reporting requirements in your state. You can find the contact information for your state health department at the following website: http://www.cdc.gov/mmwr/international/relres.html
Reporting to CDC
A provisional report of probable, and confirmed cases should be sent to the National Notifiable Diseases Surveillance System by the state health department via the National Electronic Telecommunications System for Surveillance (NETSS) or National Electronic Disease Surveillance System (NEDSS). Reporting should not be delayed because of incomplete information or lack of confirmation; following completion of case investigations, data previously submitted to NETSS or NEDSS should be updated with the available new information.
Information to Collect
A detailed case investigation of each case should be conducted. Basic demographic information (age, race or ethnicity, sex, county, and country of birth), date of onset of symptoms, and mumps vaccination history allow cases to be characterized and also allow identification of groups at increased risk of disease.
The following data elements are epidemiologically important and should be collected in the course of a case investigation. Additional information may be collected at the direction of the state health department.
Demographic Information
- Name
- Address
- Date of birth
- Age
- Sex
- Ethnicity
- Race
- Country of birth
- Length of time in U.S.
Reporting Source
- County
- Earliest date reported
Clinical
- Date of illness onset, especially parotitis
- Duration of parotitis
- Spectrum of symptoms
- Parotitis or other salivary gland involvement (only pain, tenderness, swollen)
- Other symptoms (e.g., headache, anorexia, fatigue, fever, body aches, stiff neck, difficulty in swallowing, nasal congestion, cough, earache, sore throat, nausea, abdominal pain)
- Hospitalizations and druation os stay - association to mumps
- Complications
- Meningitis
- Deafness (transient or permanent)
- Encephalitis
- Orchitis
- Other
- Outcome (case survived or died)
- Date of death
- Postmortem examination results
- Death certificate diagnosis
Treatment
- Medications given
- Duration
Laboratory
- Virus isolation
- Serology
Vaccine Information
- Dates of mumps vaccination
- Number of doses of vaccine given
- Manufacturer of vaccine
- Vaccine lot number
- If not vaccinated, reason
Epidemiological
- Epi-Linkages
- Transmission setting (e.g., college)
- Source of exposure
- Import status*
- Travel history
*An internationally imported case is defined as a case in which mumps results from exposure to mumps virus outside the United States (U.S.) as evidenced by at least some of the exposure period (12-25 days before onset of symptoms) occurring outside the U.S. and symptom onset occurring within 25 days of entering the U.S. and there is no known exposure to mumps in the U.S. during that time.
Return to Mumps Outbreaks page
Content last reviewed on January 5, 2007
Content Source: National Center for Immunization and Respiratory Diseases